Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

Zynerba Pharmaceuticals, Inc (ZYNE)

Pharmaceutical Preparations

http://www.zynerba.com

Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists of Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/05/2015

Market Cap

70,121,220

Shares Outstanding

53,940,000

Weighted SO

53,939,431

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

JUPW --.--%

SXTC --.--%

ACOR --.--%

FLGC --.--%

CLVR --.--%

IMCC --.--%

KHRNF --.--%

ALID --.--%

BFRI --.--%

Beta

1.1932

Last Div

0.0000

Range

0.25-1.4

Chg

0.0300

Avg Vol

1043239

Mkt Cap

70121220

Exch

NASDAQ

Country

US

Phone

484 581 7505

DCF Diff

1.7272

DCF

2.7972

Div Yield

0.0000

P/S

0.0000

EV Multiple

-0.8979

P/FV

2.2465

Div Yield %

0.0000

P/E

-1.7616

PEG

-0.1208

Payout

0.0000

Current Ratio

3.4301

Quick Ratio

3.2539

Cash Ratio

3.1396

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0248

ROA

-0.9143

ROE

-0.8866

ROCE

-1.3365

NI/EBT

0.9848

EBT/EBIT

0.9690

EBIT/Rev

0.0000

Debt Ratio

0.0054

D/E

0.0075

LT Debt/Cap

0.0000

Total Debt/Cap

0.0075

Int Coverage

76.8830

CF/Debt

-145.2272

Equity Multi

1.3948

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.6309

FCF/Share

-0.6349

Cash/Share

0.7172

OCF/Sales

0.0000

FCF/OCF

1.0063

CF Coverage

-145.2272

ST Coverage

-145.2272

CapEx Coverage

-157.8578

Div&CapEx Cov

-157.8578

P/BV

2.2465

P/B

2.2465

P/S

0.0000

P/E

-1.7616

P/FCF

-2.2021

P/OCF

-2.0604

P/CF

-2.0604

PEG

-0.1208

P/S

0.0000

EV Multiple

-0.8979

P/FV

2.2465

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation